Viridian Therapeutics, Inc. (VRDN)

22.43 +1.63 (+7.84%) USD  |  NASDAQ  |  Oct 20, 16:00
22.49 +0.06 (+0.27%) After-Hours: 20:00
More

Viridian Therapeutics Gross Profit (TTM) : 70.26M for June 30, 2026

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 70.26M
March 31, 2026 69.85M
December 31, 2025 69.59M
September 30, 2025 69.73M
June 30, 2025 -0.778M
March 31, 2025 -1.01M
December 31, 2024 -1.038M
September 30, 2024 -1.265M
June 30, 2024 -1.284M
March 31, 2024 -1.174M
December 31, 2023 -1.008M
September 30, 2023 -0.73M
June 30, 2023 -0.467M
March 31, 2023 -0.008M
December 31, 2022 0.175M
September 30, 2022 -0.243M
June 30, 2022 -0.243M
March 31, 2022 -0.342M
December 31, 2021 -0.418M
September 30, 2021 0.00
June 30, 2021 -0.20M
March 31, 2021 -0.20M
December 31, 2020 -0.20M
September 30, 2020 -0.20M
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 4.715M
September 30, 2018 4.715M
June 30, 2018 4.715M
March 31, 2018 4.715M
December 31, 2017 0.00
September 30, 2017 0.064M
June 30, 2017 0.354M
March 31, 2017 0.60M
December 31, 2016 0.789M
September 30, 2016 0.928M
June 30, 2016 0.562M
March 31, 2016 0.372M
December 31, 2015 0.068M
September 30, 2015 -0.3903M
June 30, 2015 0.1152M
March 31, 2015 0.657M
December 31, 2014 1.168M
September 30, 2014 1.800M
June 30, 2014 1.682M
December 31, 2013 1.713M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. 10.94B
TG Therapeutics, Inc. 658.60M
Travere Therapeutics, Inc. 519.70M
ACADIA Pharmaceuticals, Inc. 1.038B
Alnylam Pharmaceuticals, Inc. 3.827B